Search research articles
Contact Us
Filters
Showing results (61-70 of 93) with videos related to
Page
of 10
Sort By:
International Journal for Parasitology
|
October 13, 2016
Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy
Kayode K Ojo, Sriveny Dangoudoubiyam, Shiv K Verma, et al.
Molecular and Biochemical Parasitology
|
June 20, 2024
Pyridopyrimidinones as a new chemotype of calcium dependent protein kinase 1 (CDPK1) inhibitors for Cryptosporidium
Elise Waldron-Young, Wissarut Wijitrmektong, Ryan Choi, et al.
Antimicrobial Agents and Chemotherapy
|
May 8, 2019
Treatment with Bumped Kinase Inhibitor 1294 Is Safe and Leads to Significant Protection against Abortion and Vertical Transmission in Sheep Experimentally Infected with Toxoplasma gondii during Pregnancy
Roberto Sánchez-Sánchez, Ignacio Ferre, Michela Re, et al.
International Journal of Antimicrobial Agents
|
July 25, 2020
Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in mice
Nicoleta Anghel, Pablo A Winzer, Dennis Imhof, et al.
The Journal of Infectious Diseases
|
April 20, 2026
Effective Treatment using Bumped Kinase Inhibitor 1708 in a Calf Clinical Model of Cryptosporidiosis
Deborah A Schaefer, Dana P Betzer, Kevin Ackman, et al.
Plos One
|
April 22, 2021
High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity
Ryan Choi, Mowei Zhou, Roger Shek, et al.
Antimicrobial Agents and Chemotherapy
|
February 13, 2019
Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of <i>Cryptosporidium</i> Infection
Frederick S Buckner, Ranae M Ranade, J Robert Gillespie, et al.
The Journal of Infectious Diseases
|
November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis
Matthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 9, 2025
Architecture of <i>Pseudomonas aeruginosa</i> glutamyl-tRNA synthetase defines a subfamily of dimeric class Ib aminoacyl-tRNA synthetases
Michael K Fenwick, Stephen J Mayclin, Steve Seibold, et al.
European Journal of Medicinal Chemistry
|
February 18, 2014
Development of potent and selective Plasmodium falciparum calcium-dependent protein kinase 4 (PfCDPK4) inhibitors that block the transmission of malaria to mosquitoes
Rama Subba Rao Vidadala, Kayode K Ojo, Steven M Johnson, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 93) with videos related to
Sort By:
Page
of 10
International Journal for Parasitology
|
October 13, 2016
Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy
Kayode K Ojo, Sriveny Dangoudoubiyam, Shiv K Verma, et al.
Molecular and Biochemical Parasitology
|
June 20, 2024
Pyridopyrimidinones as a new chemotype of calcium dependent protein kinase 1 (CDPK1) inhibitors for Cryptosporidium
Elise Waldron-Young, Wissarut Wijitrmektong, Ryan Choi, et al.
Antimicrobial Agents and Chemotherapy
|
May 8, 2019
Treatment with Bumped Kinase Inhibitor 1294 Is Safe and Leads to Significant Protection against Abortion and Vertical Transmission in Sheep Experimentally Infected with Toxoplasma gondii during Pregnancy
Roberto Sánchez-Sánchez, Ignacio Ferre, Michela Re, et al.
International Journal of Antimicrobial Agents
|
July 25, 2020
Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in mice
Nicoleta Anghel, Pablo A Winzer, Dennis Imhof, et al.
The Journal of Infectious Diseases
|
April 20, 2026
Effective Treatment using Bumped Kinase Inhibitor 1708 in a Calf Clinical Model of Cryptosporidiosis
Deborah A Schaefer, Dana P Betzer, Kevin Ackman, et al.
Plos One
|
April 22, 2021
High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity
Ryan Choi, Mowei Zhou, Roger Shek, et al.
Antimicrobial Agents and Chemotherapy
|
February 13, 2019
Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of <i>Cryptosporidium</i> Infection
Frederick S Buckner, Ranae M Ranade, J Robert Gillespie, et al.
The Journal of Infectious Diseases
|
November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis
Matthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 9, 2025
Architecture of <i>Pseudomonas aeruginosa</i> glutamyl-tRNA synthetase defines a subfamily of dimeric class Ib aminoacyl-tRNA synthetases
Michael K Fenwick, Stephen J Mayclin, Steve Seibold, et al.
European Journal of Medicinal Chemistry
|
February 18, 2014
Development of potent and selective Plasmodium falciparum calcium-dependent protein kinase 4 (PfCDPK4) inhibitors that block the transmission of malaria to mosquitoes
Rama Subba Rao Vidadala, Kayode K Ojo, Steven M Johnson, et al.
Page
of 10